Bulls, Bears: Sepsis and Anti-Infectives in the Public Markets

The threat of infection in hospital and other treatment facilities have dramatically increased over the last few years. Antibiotics and other therapies have become impotent against certain pathogens and infections, increasing the need for research funding for creating new antibiotics. These three companies have the potential to solve a significant unmet medical need.

Read more »

Boston Scientific to Introduce Two New Devices at the New Cardiovascular Horizons Conference

The Massachusetts based company is a worldwide developer, manufacturer and marketer of medical devices.

Read more »

Spotlight Back on Sudden Cardiac Arrest

Recent news reports of young American athletes collapsing on the field have drawn media attention to sudden cardiac arrest, a leading cause of death in the U.S.

Read more »

Healthcare Reform: Who Wins?

If nothing else, the healthcare reform bill has been fantastic at sparking debate.

Read more »

Good News for Market-Leading Stent

A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events plateaued at 6.4% in the second and third years after Xience was implanted.

Read more »